Call (314) 366-4874
For more information on the naming of this product CLICK HERE Delta Sleep-Inducing Peptide, or DSIP, is a nonapeptide first isolated from rabbit cerebral venous blood back in 1974 by Marcel Monniers Swiss research team
- including CLA - 240 mg - including polyphenols 50% - 100 mg - including caffeine 9% - 18 mg 1 serving (1 capsule), preferably before exercise
Jen Pfleghaar, DO, is a double board-certified physician in Emergency Medicine and Integrative Medicine specializing in womens hormone health, metabolic medicine, and longevity science
A new indication for Wegovy The Therapeutic Goods Administration (TGA) granted approval in December 2024 for semaglutide 2.4mg, sold under the brand name Wegovy, to be used as a complementary therapy for adults with both cardiovascular disease and high body mass index, to reduce the related risk of heart attack, stroke or death
Subcutaneous injection protocol: Starting dose: 200 to 300 mcg daily Titration: Increase by approximately 100 mcg every 1 to 2 weeks as tolerated Target dose: 400 to 500 mcg daily by weeks 5 through 12 Frequency: Once daily, subcutaneous Cycle length: 8 to 12 weeks, with optional extension to 16 weeks Timing: Consistent daily timing, typically evening for sleep applications Oral/sublingual protocol: Duration: 30 days Frequency: 1 to 4 cycles per year Best combined with: Exercise and nutrient-rich diet Injection sites should be rotated between the abdomen, thighs, and upper arms to prevent lipohypertrophy and ensure consistent absorption
